Should PPIs be given to patients on antiplatelet drugs?

被引：1
|
作者：
Vavricka, Stephan R. [1 ]
Wildi, Stephan M. [1 ]
Fried, Michael [1 ]
机构：
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2006年 / 3卷 / 08期
关键词：
antiplatelet drugs; PPIs; risk; upper gastrointestinal bleeding;
D O I：
10.1038/ncpgasthep0559
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
  • [1] Should PPIs be given to patients on antiplatelet drugs?
    Stephan R Vavricka
    Stephan M Wildi
    Michael Fried
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 428 - 429
  • [2] Should patients in need be given access to experimental drugs?
    Caplan, Arthur L.
    Bateman-House, Alison
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1275 - 1279
  • [3] Patients should continue anticoagulants or antiplatelet drugs after gastrointestinal bleeding
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (10) : 564 - 564
  • [4] Should critical care patients receive or remain on treatment with antiplatelet drugs?
    Mahajan, Ravi
    Heptinstall, Stan
    CRITICAL CARE MEDICINE, 2010, 38 (01) : 298 - 300
  • [5] Long term anticoagulation or antiplatelet treatment - Patients at risk of stroke should be given warfarin
    Evans, A
    Kalra, L
    BRITISH MEDICAL JOURNAL, 2001, 323 (7306): : 234 - 235
  • [6] Should patients on long term immunosuppressive drugs be given antituberculous chemoprophylaxis?
    Whitfield, R
    THORAX, 2003, 58 : 56 - 56
  • [7] Patients should be given more information about drugs during consultations
    Schofield, TP
    BRITISH MEDICAL JOURNAL, 1996, 313 (7068): : 1330 - 1330
  • [8] Antimetastatic activity of selected pyridinium salts given in a combination with antiplatelet drugs
    Blazejczyk, Agnieszka
    Switalska, Marta
    Chlopicki, Stefan
    Marcinek, Andrzej
    Gebicki, Jerzy
    Wietrzyk, Joanna
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 366 - 367
  • [9] WHO SHOULD ADMINISTER INTRAVENOUSLY GIVEN DRUGS AND AGENTS
    YOKES, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (07): : 1063 - 1063
  • [10] Should aspirin and PPIs be recommended for patients with Barrett's oesophagus?
    Hvid-Jensen, Frederik
    Drewes, Asbjorn Mohr
    LANCET, 2018, 392 (10145): : 362 - 364
12345